Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

C Axfors, P Janiaud, AM Schmitt, J van't Hooft… - BMC infectious …, 2021 - Springer
Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only …

Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis

K Dahms, A Mikolajewska, K Ansems… - European journal of …, 2023 - Springer
Background At the end of 2021, the European Medicines Agency (EMA) expanded its
approval for the recombinant human interleukin-1 (IL-1) receptor antagonist Anakinra for the …

Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis

N Mihalek, D Radovanović, O Barak, P Čolović… - Scientific Reports, 2023 - nature.com
Insight into the clinical potential of convalescent plasma in patients with coronavirus disease
(COVID-19) is important given the severe clinical courses in unvaccinated and seronegative …

Efficacy of tocilizumab in the treatment of COVID‐19: An umbrella review

MM Rezaei Tolzali, M Noori, P Shokri… - Reviews in Medical …, 2022 - Wiley Online Library
Tocilizumab is an interleukin (IL)‐6 receptor inhibitor that has been proposed as a
therapeutic agent for treating coronavirus disease 2019 (COVID‐19). The aim of this …

[HTML][HTML] Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic …

YJ Han, KH Lee, S Yoon, SW Nam, S Ryu, D Seong… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract Rationale: Coronavirus disease 2019 (COVID-19) has spread worldwide and poses
a threat to humanity. However, no specific therapy has been established for this disease yet …

Safety and efficacy of convalescent plasma in COVID-19: an overview of systematic reviews

M Franchini, F Corsini, D Focosi, M Cruciani - Diagnostics, 2021 - mdpi.com
Convalescent plasma (CP) from patients recovered from COVID-19 is one of the most
studied anti-viral therapies against SARS-COV-2 infection. The aim of this study is to …

Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study

JA Ruíz-Quiñonez, CG Guzmán-Priego… - PLoS …, 2021 - journals.plos.org
Background Due to the wide spread of SARS-CoV2 around the world, the risk of death in
individuals with metabolic comorbidities has dangerously increased. Mexico has a high …

Meta-analyses do not establish improved mortality with ivermectin use in COVID-19

SG Rothrock, KD Weber, PA Giordano… - American journal of …, 2022 - journals.lww.com
All authors (SG Rothrock, KD Weber, M. Barneck, PA Giordano) were involved in conception
of study, design of the study, data collection and abstraction, drafting and revision of the …

Convalescent plasma for the treatment of severe COVID-19

M Franchini, GM Liumbruno - Biologics: Targets and Therapy, 2021 - Taylor & Francis
The COVID-19 pandemic in 2020 is one of the worst catastrophic events in human history.
Several non-specific antiviral drugs have been tried to defeat the SARS-CoV-2, with mixed …

Effect of tocilizumab in reducing the mortality rate in COVID-19 patients: a systematic review with meta-analysis

V Conti, G Corbi, C Sellitto, F Sabbatino… - Journal of Personalized …, 2021 - mdpi.com
Data supporting the use of Tocilizumab (TCZ) in COVID-19 are contrasting and inconclusive.
This meta-analysis aimed to assess TCZ effectiveness in reducing the mortality rate in …